New research shows COVID-19 raises the risk of Guillain-Barré syndrome more than vaccines. mRNA vaccines pose no increased risk, global data reveals.

Overall, COVID-19 vaccine-induced side effects in elderly populations were rare. We concluded that the vaccine’s efficacy in preventing excess deaths due to COVID-19 is significant, and the risk of ...

Chris Nemeth, 51, from Melbourne worked in airline logistics until he got the AstraZeneca vaccine in July 2021 and developed ...

Dr. William Dugal experienced total paralysis after developing Guillain-Barre syndrome. After a year of rehabilitation, he's back to working as surgeon.

Covid: According to the World Health Organisation (WHO), Guillain-Barre syndrome is a rare autoimmune condition in which a person's immune system attacks their peripheral nerves.

Researchers found a link between covid-19 and Guillain-Barré syndrome, while also finding that mRNA vaccination may lower the risk.

WEDNESDAY, Oct. 18, 2023 (HealthDay News) -- COVID infection can raise the risk of a rare immune system attack on the body's nerves -- but vaccination might protect against it, a large new study ...

A new study indicates that COVID-19 is associated with an elevated risk of a rare disorder, Guillain-Barré syndrome, within six weeks after infection with the virus.

Poliovirus has at no point been renamed Guillain-Barré syndrome (GBS) and it is not a side effect of COVID-19 vaccines. Poliovirus infection can cause GBS but incidents are rare, one expert told ...